Equity Details
Price & Market Data
Price: $237.7
Daily Change: -$1.02 / 0.43%
Daily Range: $237.0 - $245.0
Market Cap: $14,681,957,376
Daily Volume: 822,851
Performance Metrics
1 Week: 5.49%
1 Month: -4.39%
3 Months: 6.00%
6 Months: 20.18%
1 Year: 53.89%
YTD: 11.45%
About Ascendis Pharma A/S (ASND)
Comprehensive data for Ascendis Pharma A/S (ASND) is available. Current price is 237.7, with a daily change of -$1.02 / 0.43%. Market cap is 14,681,957,376. View detailed performance metrics for all periods, including YTD, 1-week, 1-month, 3-month, 6-month, and 1-year returns.
Details
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.